Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO RESEARCH IN CARDIOVASCULAR

August 2025

CARDIOVASCULAR

THE IMPORTANCE OF DIAGNOSTIC IMAGING IN EARLY HFPEF

Featuring: Hidenori Yaku, MD, PhD, and Sanjiv J. Shah, MD
Heart failure with preserved ejection fraction (HFpEF) is the most common type of heart failure. Early identification of patients with early HFpEF  is critical due to the high mortality and morbidity of advanced HFpEF. However, diagnosing HFpEF can be particularly challenging due to a lack of obvious signs that can be detected by physician exam and in biomarker and imaging studies.

A review by Hidenori Yaku, MD, PhD, and Sanjiv J. Shah, MD, published in JACC: Cardiovascular Imaging, highlights how advanced diagnostic tools, such as exercise stress echocardiography, cardiopulmonary exercise testing with imaging and right heart catheterization can significantly improve early detection of early HFpEF.

​The authors also discuss ongoing clinical trials to develop more personalized and effective therapies for early HFpEF, including the HeartShare Deep Phenotyping Study led by Dr. Shah.
​
“In 2007, we developed the first dedicated HFpEF clinical program in the world here at Northwestern, and since that time have been a leading center for research, clinical trial enrollment and clinical care of HFpEF patients,” Dr. Shah says. “The HeartShare grant from the NIH is a phenomenal opportunity to continue our research to improve the classification of the heterogeneous HFpEF syndrome, understand the biological basis of HFpEF phenotypes and set the stage for precision medicine clinical trials for HFpEF.
Read the review.
Sadiya S. Khan, MD, MSc headshot
​Sanjiv J. Shah, MD, Director of Institute for Artificial Intelligence in Medicine in the Center for Deep Phenotyping and Precision Therapeutics; Neil J. Stone, MD, Professor, Professor of Cardiology
Picture
Hidenori Yaku, MD, PhD, Post-doctoral Fellow in Department of ​Cardiology

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​
Refer to Us
Find a Cardiovascular Physician

You May Also Like

Video still of Sanjiv J. Shah, MD
​

August 2025

CARDIOVASCULAR
C. Charles Jain, MD, Discusses Advancing Care for Adult Congenital Heart Disease
Video still of Rod S. Passman, MD

July 2025

CARDIOVASCULAR
PREVENT-HF and the Importance of Risk-Based Heart Failure Prevention
Podcast graphic with headshots of Mohamed M. Al-Kazaz, MD and Paul C. Cremer, MD

June 2025

CARDIOVASCULAR
Daniel R. Schimmel, MD, on Advancing Care for CTEPH

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties